Relative Etiological Role of Prior Hepatitis B Virus Infection and Nonalcoholic Fatty Liver Disease in the Development of Non-B Non-C Hepatocellular Carcinoma in a Hepatitis B-endemic Area
Overview
Authors
Affiliations
Background And Aims: We investigated the relative etiological role of prior hepatitis B virus (HBV) infection and nonalcoholic fatty liver disease (NAFLD) in the development of non-B non-C, non-alcohol or specific cause-related hepatocellular carcinoma (NBNC-NA-NS HCC) in an HBV-endemic area of Korea.
Methods: A total of 329 patients with NBNC-NA-NS HCC were enrolled in this study. Prior HBV infection was defined as the presence of isolated IgG hepatitis B core antibody (anti-HBc), and NAFLD was diagnosed by the findings from the imaging in the absence of a history of excessive alcohol consumption.
Results: Prior HBV infection was the most common cause of underlying liver disease (76.6%). Only 8.2% of the patients had NAFLD as the only risk factor and the same proportion of patients had evidence of both prior HBV infection and NAFLD. Patients without definitive causes accounted for 7.0% of the cases. During the past 10 years, the relative proportion of isolated IgG anti-HBc-positive HCC decreased significantly from 86.6% in 2001-2005 to 67.4% in 2006-2010 (p < 0.0001) and that of NAFLD-related HCC increased from 3.8% to 12.2% in the same period, respectively (p = 0.008). The mean age of NAFLD-related HCC patients (67.3 years) was significantly older than that of HCC patients related to prior HBV infection (61.2 years, p < 0.001).
Conclusions: NAFLD-related HCC increased significantly while HCC related to prior HBV infection decreased during the past 10 years in an HBV-endemic area of Korea; however, the relative etiological role of prior HBV infection was still greater than that of NAFLD in the development of NBNC-NA-NS HCC.
International perspectives on LI-RADS.
Kierans A, Aguirre D, Krishan S, Lee J, Ronot M, Wang J Abdom Radiol (NY). 2024; .
PMID: 39699666 DOI: 10.1007/s00261-024-04729-3.
Global Epidemiology of Hepatocellular Carcinoma.
Singh S, Madke T, Chand P J Clin Exp Hepatol. 2024; 15(2):102446.
PMID: 39659901 PMC: 11626783. DOI: 10.1016/j.jceh.2024.102446.
Mak L, Liu K, Chirapongsathorn S, Yew K, Tamaki N, Rajaram R Nat Rev Gastroenterol Hepatol. 2024; 21(12):834-851.
PMID: 39147893 DOI: 10.1038/s41575-024-00967-4.
Jean K, Tawheed A, Luong Nguyen L, Heikal T, Eldaly U, Gaber Elhadidy N J Hepatocell Carcinoma. 2024; 11:997-1004.
PMID: 38835726 PMC: 11149647. DOI: 10.2147/JHC.S455832.
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide.
Kim D J Liver Cancer. 2024; 24(1):62-70.
PMID: 38523466 PMC: 10990659. DOI: 10.17998/jlc.2024.03.13.